News|Articles|June 2, 2001
- Pharmaceutical Technology-06-02-2001
- Volume 25
- Issue 6
Viral Clearance Strategies for Biopharmaceutical Safety
Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.
Advertisement
Articles in this issue
about 25 years ago
Outsourcing Outlookabout 25 years ago
Managing Risks and Resourcesabout 25 years ago
Blister News: COC Resin, Foil, and Lidding Innovationsabout 25 years ago
Managing the Risks in Outsourcingabout 25 years ago
Systemic Drug Delivery via the Buccal Mucosal RouteAdvertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
4
CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda
5